BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 95 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $305,000 | -37.6% | 5,471 | -48.9% | 1.78% | +6.2% |
Q3 2016 | $489,000 | -37.9% | 10,705 | -45.6% | 1.68% | -61.9% |
Q2 2016 | $787,000 | +2.1% | 19,695 | -11.1% | 4.40% | +108.8% |
Q1 2016 | $771,000 | -21.1% | 22,150 | -2.6% | 2.11% | +64.9% |
Q4 2015 | $977,000 | – | 22,740 | – | 1.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 285,259 | $16,685,000 | 9.76% |
JW Asset Management, LLC | 73,649 | $4,308,000 | 2.32% |
THB ASSET MANAGEMENT | 113,485 | $6,637,000 | 0.81% |
Eversept Partners, LP | 21,900 | $1,280,931 | 0.56% |
EAM Global Investors LLC | 20,642 | $1,207,000 | 0.49% |
RICE HALL JAMES & ASSOCIATES, LLC | 181,690 | $10,627,000 | 0.38% |
Elk Creek Partners, LLC | 114,230 | $6,681,000 | 0.36% |
ISTHMUS PARTNERS, LLC | 19,525 | $1,142,000 | 0.29% |
PURA VIDA INVESTMENTS, LLC | 20,160 | $1,179,000 | 0.25% |
CADENCE CAPITAL MANAGEMENT LLC | 49,363 | $2,887,000 | 0.16% |